Related Experiment Video
Updated: Feb 4, 2026

Promoter Capture Hi-C: High-resolution, Genome-wide Profiling of Promoter Interactions
Published on: June 28, 2018
Promoter Haplotypes of the ABCB1 Gene Encoding the P-Glycoprotein Differentially Affect Its Promoter Activity by
Jordan T Speidel1,2, Meixiang Xu2, Sherif Z Abdel-Rahman2
11 Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch at Galveston, Galveston, Texas.
Insights
ABCB1 gene promoter haplotypes significantly alter P-glycoprotein expression by changing transcription factor binding. Understanding these haplotype-specific effects is crucial for predicting fetal drug exposure and disease risk.
Area of Science:
- Pharmacogenomics
- Molecular biology
- Genetics
Background:
- Promoter single nucleotide polymorphisms (SNPs) in the ABCB1 gene influence P-glycoprotein (P-gp) expression, affecting fetal exposure to drugs and xenobiotics.
- ABCB1 genetic variations occur as haplotypes, not independent SNPs, and these haplotypes differentially impact gene expression.
Purpose of the Study:
- To investigate the mechanisms by which ABCB1 haplotypes alter promoter activity.
- To test the hypothesis that haplotype-specific transcription factor (TF) binding underlies differential ABCB1 promoter activity.
Main Methods:
- Utilized a transcription factor (TF) binding profile array to assess TF binding across different ABCB1 haplotypes.
- Employed small interfering RNA (siRNA) in cultured human placental cells to mechanistically evaluate the role of TFs with significant haplotype binding differences.
Main Results:
- Identified significant haplotype-dependent differences in TF binding to the ABCB1 promoter.
- Demonstrated that the regulatory impact of TFs on ABCB1 promoter activity is also haplotype-dependent.
Conclusions:
- Provided a mechanistic explanation for how ABCB1 haplotypes differentially affect P-glycoprotein promoter activity.
- Emphasized the importance of analyzing genetic variants in haplotypes, not just individual SNPs, for understanding gene expression and disease risk.
Abstract:
Promoter single nucleotide polymorphisms (SNPs) of the ABCB1 gene, encoding the placental efflux transporter P-glycoprotein, can alter its expression and affect fetal exposure to therapeutics and environmental xenobiotics. SNPs are not arrayed as independent variants but as combinations forming defined haplotypes. Recently, we defined the haplotypes encompassing ABCB1 promoter SNPs and found that ABCB1 haplotypes differentially affect its promoter activity. The mechanism(s) by which ABCB1 haplotypes alter its promoter activity are not known. We hypothesize that the haplotype-dependent differences in ABCB1 promoter activity are due to haplotype-specific alterations in transcription factor (TF) binding. To test our hypothesis, we used a TF binding profile array and determined whether differences in TF binding exist across different ABCB1 haplotypes. TFs showing significant haplotype binding differences were mechanistically evaluated using small interfering RNA (siRNA) in cultured human placental cells. Our data indicate significant haplotype-dependent differences in TF binding. Our siRNA studies showed that the regulatory effects of TFs on promoter activity are also haplotype dependent. Our data provide a mechanistic explanation for the differential effects of ABCB1 haplotypes on its promoter activity and underscore the importance of evaluating genetic variants in the context of haplotypes rather than individual SNPs when investigating their effects on gene/protein expression and disease risk.
Related Concept Videos
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Transcription Factors
Transcription Elongation Factors
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...

